Changes in the Supervisory Board of the LTS AG
On June 28th 2019, the shareholders meeting of the LTS AG has elected the four represen¬tatives of the equity owners to the supervisory board of the LTS AG.
1
07. 2019
19
03. 2019
LEO Pharma A/S and LTS Lohmann Therapie-Systeme AG initiate first-ever clinical trial of microarray patches for psoriasis treatment
LTS Lohmann Therapie-Systeme AG (LTS), a market leader in transdermal therapeutic systems, and LEO Pharma A/S, a global leader in dermatology, today announced that the companies will start the clinical trial of microarray patches for the local intradermal treatment of psoriasis.
21
02. 2019
Dr. Reddy’s re-launches generic of Buprenorphine and Naloxone Sublingual Film
LTS congratulates its business partner Dr. Reddy’s Laboratories Ltd. for the US launch of its Buprenorphine and Naloxone Sublingual Film.
20
02. 2019
EsoCap announces kick-off of an industrial development collaboration with LTS
EsoCap AG and LTS Lohmann Therapy-Systeme AG announced the start of cooperation on industrial development of a unique drug delivery technology for diseases of the upper gastrointestinal tract.
4
02. 2019
LTS AG donates a new pediatric anaesthesia trolley to the St. Nikolaus-Stifts Hospital in Andernach.
In January members of the Association, along with Dr. Torsten Baehner, head physician of the Anaesthesia and IC unit at St. Nikolaus-Stift Hospital, displayed the trolley for Ulrich Sielaff, member of the board at LTS.
